Alzheimer Disease: all 3,765 studies
Page 30 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's DiseaseCompletedNCT02260674Phase 2
- Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) ProtocolCompletedNCT02260167Not applicable
- The PLasma for Alzheimer SymptoM Amelioration (PLASMA) StudyCompletedNCT02256306Not applicable
- Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAsCompletedNCT02253732Not applicable
- The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's DiseaseStatus unknownNCT02253043Not applicable
- An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian PopulationTerminatedNCT02249468
- Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer TypeCompletedNCT02249403Phase 2
- Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer TypeTerminatedNCT02249351Phase 2
- Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer TypeTerminatedNCT02248116Phase 2/3
- Cognitive Rehabilitation in Alzheimer's DiseaseStatus unknownNCT02247180Not applicable
- Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving MemantineWithdrawnNCT02246075Phase 2
- Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's DiseaseCompletedNCT02244541Phase 2
- Brain-Computer Interface System for Training Memory and Attention in ElderlyCompletedNCT02228187Phase 2
- A Pilot Study of tDCS for Mild to Moderate Alzhemier's DiseaseStatus unknownNCT02227953Not applicable
- Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of DementiaCompletedNCT02224326
- Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild ADCompletedNCT02221622Phase 1
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsTerminatedNCT02220738Phase 1
- Alzheimer's Disease, Art and GardenStatus unknownNCT02208193Not applicable
- Adaptive Cognitive Training in Healthy Older AdultsCompletedNCT02205710Not applicable
- Cognition And Neocortical Volume After StrokeCompletedNCT02205424
- LIWA for Treatment of Alzheimer PatientsStatus unknownNCT02204969Phase 1/2
- Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years OldCompletedNCT02198586
- Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.Status unknownNCT02195596Not applicable
- Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or PlaceboCompletedNCT02192554
- Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's DementiaCompletedNCT02190084Phase 4
- Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) ParticipantsCompletedNCT02187627Phase 1
- The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed DementiaCompletedNCT02187276
- A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.CompletedNCT02178124Phase 1
- Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's DiseaseCompletedNCT02176629Not applicable
- A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the ElderlyCompletedNCT02172612Not applicable
- Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's TypeTerminatedNCT02168920Phase 3
- Effects of a NeuroAD System, for the Treatment of Alzheimer DiseaseTerminatedNCT02166827Not applicable
- Longitudinal Study of Brain Amyloid imaGing in MEMENTOCompletedNCT02164643Phase 3
- Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical PracticeCompletedNCT02162264
- Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's DiseaseCompletedNCT02162251
- A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease PatientsCompletedNCT02158910
- Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)TerminatedNCT02149017Phase 1/2
- Personalized Music Therapy and Agitation in DementiaStatus unknownNCT02147652Not applicable
- S-Equol in Alzheimer's Disease (SEAD) TrialCompletedNCT02142777Phase 1
- Down Syndrome Biomarker Initiative (DSBI)CompletedNCT02141971
- Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's DiseaseCompletedNCT02137460
- Amyloid Accumulation After Mild Traumatic Brain InjuryStatus unknownNCT02134041
- Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy VolunteersWithdrawnNCT02130661Phase 1
- Olfactory Neuroepithelial Tissue of Alzheimer DiseaseCompletedNCT02129452
- A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's DiseaseCompletedNCT02127476Phase 1
- Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's DiseaseCompletedNCT02119546Not applicable
- Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort StudyCompletedNCT02114372
- Porphyromonas Gingivalis and Alzheimer's DiseaseCompletedNCT02109705
- Yogic Breathing Changes Salivary ComponentsCompletedNCT02108769Not applicable
- Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy SubjectsCompletedNCT02103894Phase 1
- DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of DementiaCompletedNCT02103673Phase 2
- A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's DiseaseCompletedNCT02094729Phase 1
- African American Alzheimer's Progression Markers - CSF and Neuro-ImagingCompletedNCT02089555
- Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease PatientsTerminatedNCT02085265Phase 2
- Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With DementiaCompletedNCT02078310Phase 1/2
- Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's DiseaseCompletedNCT02074215Not applicable
- Oxaloacetate Pharmacokinetics and SafetyCompletedNCT02063308Not applicable
- Brain Changes by Rivastigmine According to Butyrylcholinesterase AllelesStatus unknownNCT02063269Not applicable
- PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)CompletedNCT02062099Phase 1
- A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy SubjectsCompletedNCT02061878Phase 1
- Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole FamilyCompletedNCT02055092
- Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's DiseaseCompletedNCT02054208Phase 1/2
- Co-LEsions in Alzheimer Disease and Related DisordersStatus unknownNCT02052947Not applicable
- Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?Status unknownNCT02051244
- Computational Tools for Early Diagnosis of Memory DisordersCompletedNCT02050464
- Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer DiseaseCompletedNCT02045056Early Phase 1
- The Detection of Early Dementia With the Digital Game MemoryCompletedNCT02041728
- AZD3293 Thorough QT Study in Healthy Male VolunteersCompletedNCT02040987Phase 1
- Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's DiseaseCompletedNCT02035982Phase 3
- Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)TerminatedNCT02033941Phase 2
- 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's DiseaseCompletedNCT02031198Phase 1
- Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese PhysiciansWithdrawnNCT02029547Not applicable
- CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's DiseaseCompletedNCT02021682
- Music Therapy in Alzheimer's DiseaseTerminatedNCT02020356Not applicable
- Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI StudyStatus unknownNCT02018913
- A Phase III Trial of Nilvadipine to Treat Alzheimer's DiseaseCompletedNCT02017340Phase 3
- Cognitive Behavioural Therapy for Persons With MCI or Mild DementiaStatus unknownNCT02013518Not applicable
- Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant MenCompletedNCT02010476
- Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006TerminatedNCT02008513Phase 2
- Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease RehabilitationCompletedNCT02005380
- Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025TerminatedNCT02004392Phase 3
- Impact of a Memory Group for Older Adults Reporting Memory DifficultiesCompletedNCT01998711Not applicable
- Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))Status unknownNCT01993628Not applicable
- Genistein as a Possible Treatment for Alzheimer's Disease.CompletedNCT01982578Not applicable
- Korea Alzheimer's Disease Neuroimaging InitiativeStatus unknownNCT01979419
- A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's DiseaseCompletedNCT01978548Phase 1
- GSK2647544 RD, DDI in Healthy Young and Elderly VolunteersTerminatedNCT01978327Phase 1
- The Effect of Repeated Transcranial Magnetic Stimulation on Off-line Resting Electroencephalographic Signal in Alzheimer's DiseaseTerminatedNCT01970150Not applicable
- Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseTerminatedNCT01969136Phase 3
- Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseTerminatedNCT01969123Phase 3
- A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's DiseaseCompletedNCT01966666Phase 1
- Sleep, Aging and Risk for Alzheimer's DiseaseCompletedNCT01962779Not applicable
- Effects of Aerobic Exercise for Treating Alzheimer's DiseaseCompletedNCT01954550Not applicable
- n-3 PUFA for Vascular Cognitive AgingStatus unknownNCT01953705Phase 2
- Zydena on Cognitive Function of Alzheimer's Disease PatientsStatus unknownNCT01940952Phase 3
- Novel Retinal Imaging Biomarkers in Early Alzheimer's DiseaseCompletedNCT01937221
- Benefits of Exercise in Alzheimer's DiseaseStatus unknownNCT01935024Not applicable
- A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's DiseaseCompletedNCT01928420Phase 2
- Predictors for Poststroke Outcomes: Tel Aviv Brain Acute Stroke Cohort Acute Stroke Cohort (TABASCO)CompletedNCT01926691
- A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related DisordersCompletedNCT01926249